Eliminating cervical cancer: progress and challenges for high income countries

Jennifer Davies-Oliveira, M.A. Smith, S. Grover, Karen Canfell, Emma Crosbie

Research output: Contribution to journalArticlepeer-review

92 Downloads (Pure)


In 2020, the World Health Organization launched a major initiative to eliminate cervical cancer globally. The initiative is built around the three key pillars of human papillomavirus (HPV) vaccination, cervical screening and treatment, with associated intervention targets for the year 2030. The ‘90-70-90’ targets specify that 90% of adolescent girls receive prophylactic HPV vaccination, 70% of adult women receive a minimum twice-in-a-lifetime cervical HPV test and 90% receive appropriate treatment for preinvasive or invasive disease. Modelling has shown that if these targets are met, the elimination of cervical cancer, defined as fewer than four cases per 100 000 women per annum, will be achieved within a century. Many high-income countries are well positioned to eliminate cervical cancer within the coming decades, but few have achieved ‘90-70-90’ and many challenges must still be addressed to deliver these critical interventions effectively. This review considers the current status of cervical cancer control in relation to each of the three elimination pillars in high-income countries and discusses some of the developments that will assist countries in reaching these ambitious targets by 2030.
Original languageEnglish
JournalClinical Oncology
Publication statusPublished - 24 Jul 2021

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre


Dive into the research topics of 'Eliminating cervical cancer: progress and challenges for high income countries'. Together they form a unique fingerprint.

Cite this